Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Spine Biologics Companies

Spine biologics refer to advanced medical products designed to enhance the natural healing processes of the spine. These products often include biological materials, such as proteins, growth factors, and stem cells, which are used to promote tissue regeneration and improve the overall outcome of spinal surgeries.

Spine Biologics Key Companies

Latest Spine Biologics Companies Update:

Medtronic (US) Acquired Mazo BioSciences, Inc. (US) in August 2023, strengthening its biologics portfolio with Mazo's Osteocel Plus® bone graft substitute, offering enhanced fusion rates and patient outcomes.

Orthofix International N.V. (Belgium) Launched its Trinity System in June 2023, a combined interbody spacer and bone graft substitute for spinal fusion surgeries, aiming to simplify surgical procedures and improve bone fusion rates.

Stryker (US) Collaborated with TissueGenesis, Inc. (US) to distribute TissueGenesis' osteochondral allograft cartilage repair solutions for spinal applications, expanding treatment options for patients with cartilage damage.

Regenerative Biologics, Inc. (US) Announced the positive reasults of a Phase II clinical trial for its Osteocel-HA bone graft substitute for spinal fusion, demonstrating improved fusion rates compared to traditional bone graft options

MiMedX Group, Inc. (US) Received FDA approval for its Puregraft® Flowable Micro DBM putty for spinal fusion procedures in July 2023, offering a moldable bone graft option for surgeons for improved surgical site adaptation.

List of Spine Biologics Key companies in the market

Arthrex, Inc.

Cesca Therapeutics Inc.

DePuy Synthes

Orthopaedic Seminar

Exactech, Inc.

K2M, Inc.

Lattice Biologics Ltd

Medtronic

NuTech Spine, Inc.

NuVasive Inc.

Orthofix Holdings, Inc.

Regen Lab USA LLC

RTI Surgical Holdings, Inc.

Stryker

Wright Medical Group N.V.

XTANT MEDICAL

Zimmer Biomet

Smith & Nephew

Dr PRP USA LLC

Spine Biologics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.